about
Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphateCharacterization of edg-2, a human homologue of the Xenopus maternal transcript G10 from endothelial cellsPTEN as an effector in the signaling of antimigratory G protein-coupled receptorRequirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interferenceSphingosine 1-phosphate signallingSphingolipid signaling in metabolic disordersS1P control of endothelial integritySphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyondCardiac and vascular effects of fingolimod: mechanistic basis and clinical implicationsNogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressureEndothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein MCyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.Characterization of a novel sphingosine 1-phosphate receptor, Edg-8International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclatureLysophospholipids--receptor revelationsMolecular characterization of the 5.2 KB isoform of the human cyclooxygenase-1 transcriptInduction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTENBisphenol A diglycidyl ether (BADGE) is a PPARgamma agonist in an ECV304 cell lineInduction of cyclooxygenase-2 in macrophages by catalase: role of NF-kappaB and PI3K signaling pathwaysSphingosine 1-phosphate receptorsSphingolipid modulation of angiogenic factor expression in neuroblastoma.International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumorInduction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2Vascular endothelium as a contributor of plasma sphingosine 1-phosphate.Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammationSphingosine-1-phosphate: extracellular mediator or intracellular second messenger?Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritisAn update on the biology of sphingosine 1-phosphate receptors.Sphingosine interaction with acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) regulates PP2A activity and cyclooxygenase (COX)-2 expression in human endothelial cells.Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.The BCL6 RD2 domain governs commitment of activated B cells to form germinal centers.Intestinal epithelial HuR modulates distinct pathways of proliferation and apoptosis and attenuates small intestinal and colonic tumor developmentPhosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability.Regulation of limb development by the sphingosine 1-phosphate receptor S1p1/EDG-1 occurs via the hypoxia/VEGF axis.Regulation of a vascular plexus by gata4 is mediated in zebrafish through the chemokine sdf1a.Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactionsInhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation.Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland.ELAVL1 modulates transcriptome-wide miRNA binding in murine macrophages
P50
Q22010773-204EE118-1BE9-4DCF-A9F7-57CC72404540Q24312108-721DA72A-CE79-4AFC-8FBB-14E25939009AQ24555751-AF36B322-C0DE-48C6-BD62-B1E7BE0DA042Q24563464-2EF3B5F7-D31B-4FCD-8930-C451080A0278Q26852942-4C978B75-9B32-4C88-AA40-B62C36E868DEQ26992148-21455D6C-C163-476A-8E9D-9A52C07A9306Q27000974-D17F08F7-B11C-47AD-8F58-C29166199FEAQ27011857-34F1D06B-72A6-42E7-A8B8-FD719026D58BQ27016109-33D832E7-D19E-42BC-961E-DEB8B71F9B67Q27315147-03365FF3-A4F4-4A6A-88E7-5B199C9FFB38Q27667968-4C63BCD2-9682-4CAE-88C8-1C84B0E87E71Q27863328-E1C32441-498F-48A9-860A-8D0FED869D2AQ28143704-953A4166-7923-4927-ADCA-1C3C7C3B797CQ28201589-02BF8BFB-CE9B-479B-8E11-7CB8D60F036BQ28208260-D93EC7F6-7C94-4FCC-9AA6-5F9A1F7583C4Q28295523-82B195CD-B1CE-4212-BBBA-095B684FEAB3Q28297849-D90BABF4-4753-4349-84C1-A15BD8D04BE4Q28344848-18C98034-1AF2-42B6-9837-65423848BED7Q28505206-0FBB55E1-BA7E-4D22-B30C-263504D00E0AQ29013537-0DC3927C-A9B3-4F6D-B6ED-7D8C907E4F37Q30425699-A3DF15CF-69FF-475C-95BC-0DD4417E4FC0Q30429523-C5301CA8-5D9C-4185-950D-5653EB3160D1Q30434737-B19652AA-1733-440D-9084-126EF1768C89Q30438371-98969652-44D4-4DA2-925D-40C931017976Q33378571-09DFA6CB-A472-4C6D-86C6-F3DB0232A045Q33583306-5C8453ED-DA5A-4500-928A-E72E445EC875Q33697778-75D6102E-B0D3-4EA5-8F7C-C16FD9F44E68Q33890360-83A531A3-E047-4B0E-9386-15CAF6280CFDQ33945064-559FE610-C42D-425B-B534-C39EA5A97F24Q34094319-FD9A20E7-1179-4BF2-BF01-A84A949D0757Q34132261-F028F642-632A-4CE9-88EB-1E9A211B22C9Q34175167-34158082-B563-44AB-AEF7-E92A67359378Q34205259-9D2F0B99-ED3B-4578-B3B3-6AADDDD92CABQ34227743-407A9EB5-A679-4264-A18F-F6774C733747Q34310949-742087DC-8B25-4F20-AE5C-D1AACE18DC2FQ34442283-1FE3921D-86AB-4DF5-94A6-47033BF0DF67Q34565310-B6833124-424C-4164-9C9E-CC8A71FC024EQ34748080-AADF9394-A48B-4BD0-9962-937BCCDE0303Q34764480-D9892AE3-5870-4B5D-B9EF-895FCB2B9654Q34777377-D6BECF48-3727-4865-81F9-71265A4962FF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Timothy Hla
@ast
Timothy Hla
@en
Timothy Hla
@es
Timothy Hla
@nl
Timothy Hla
@sl
type
label
Timothy Hla
@ast
Timothy Hla
@en
Timothy Hla
@es
Timothy Hla
@nl
Timothy Hla
@sl
prefLabel
Timothy Hla
@ast
Timothy Hla
@en
Timothy Hla
@es
Timothy Hla
@nl
Timothy Hla
@sl
P1053
G-5873-2012
P106
P1153
16185252300
P21
P31
P3829
P496
0000-0001-8355-4065